Design Therapeutics, Inc. (DSGN)
收市後：
| 前收市價 | 3.9400 |
| 開市 | 3.9600 |
| 買盤 | 4.0300 x 100 |
| 賣出價 | 4.0800 x 400 |
| 今日波幅 | 3.9600 - 4.0800 |
| 52 週波幅 | 1.9400 - 8.3100 |
| 成交量 | |
| 平均成交量 | 296,444 |
| 市值 | 228.805M |
| Beta 值 (5 年，每月) | 1.84 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.0400 |
| 業績公佈日 | 2024年8月12日 - 2024年8月16日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 6.67 |
InvestorPlaceThe 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
Biotech stocks are naturally an exciting area for investment. Just one therapeutic breakthrough can change the whole trajectory of the company. Millions of dollars, partnerships with big-name pharmaceuticals, or even a buyout can follow. However it entails a lot of risk. The Piper Sandler (NYSE:PIPR) investment firm says it found three biotech stocks with the winning ticket. These Piper Sandler stocks have investors curious. Piper Sandler may be the best bet for investors especially when you see
Insider MonkeyDesign Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript March 19, 2024 Design Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.32. DSGN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Design’s […]
